Main Campus: Chesterfield, MO 63017 | 
Lepromin skin test
Leprosy skin test; Hansen disease - skin test
The lepromin skin test is used to determine what type of leprosy a person has.
How the Test is Performed
A sample of inactivated (unable to cause infection) leprosy-causing bacteria is injected just under the skin, often on the forearm, so that a small lump pushes the skin up. The lump indicates that the antigen has been injected at the correct depth.
Antigen
An antigen is any substance that causes your immune system to produce antibodies against it. This means your immune system does not recognize the su...
The injection site is labeled and examined 3 days, and again 28 days later to see if there is a reaction.
How to Prepare for the Test
People with dermatitis or other skin irritations should have the test performed on an unaffected part of the body.
Dermatitis
Atopic dermatitis is a long-term (chronic) skin disorder that involves scaly and itchy rashes. It is a type of eczema. Other forms of eczema include...
If your child is to have this test performed, it may be helpful to explain how the test will feel, and even demonstrate on a doll. Explain the reason for the test. Knowing the "how and why" may reduce the anxiety your child feels.
How the Test will Feel
When the antigen is injected, there may be a slight stinging or burning. There may also be mild itching at the site of injection afterward.
Why the Test is Performed
Leprosy is a chronic and potentially disfiguring infection if left untreated. It is caused by Mycobacterium leprae bacteria.
Leprosy
Leprosy is an infectious disease that has been known since biblical times. This disease causes skin sores, nerve damage, and muscle weakness that ge...
Chronic
Chronic refers to something that continues over an extended period of time. A chronic condition is usually long-lasting and does not easily or quick...
This test is a research tool that helps classify the different types of leprosy. It is not recommended as the main method to diagnose leprosy.
Normal Results
People who don't have leprosy will have little or no skin reaction to the antigen. People with a particular type of leprosy called lepromatous leprosy will also have no skin reaction to the antigen.
What Abnormal Results Mean
A positive skin reaction may be seen in people with specific forms of leprosy, such as tuberculoid and borderline tuberculoid leprosy. People with lepromatous leprosy will not have a positive skin reaction.
Risks
There is a very small risk for an allergic reaction, which may include itching and rarely, hives .
Hives
Hives are raised, often itchy, red bumps (welts) on the surface of the skin. They are usually an allergic reaction to food or medicine. They can al...
References
Renault CA, Ernst JD. Mycobacterium leprae (leprosy). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases . 8th ed. Philadelphia, PA: Elsevier Saunders; 2015:chap 252.
Walker SL, Withington SG, Lockwood DNJ. Leprosy. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, eds. Manson's Tropical Diseases . 23rd ed. Philadelphia, PA: Elsevier; 2014:chap 41.
-
Antigen injection - illustration
Leprosy is caused by the organism Mycobacterium leprae. The leprosy test involves injection of an antigen just under the skin to determine if your body has a current or recent leprosy infection. The injection site is labeled and examined 3 days and 28 days later to see if there is a reaction. Mycobacterium leprae
Antigen injection
illustration
-
Antigen injection - illustration
Leprosy is caused by the organism Mycobacterium leprae. The leprosy test involves injection of an antigen just under the skin to determine if your body has a current or recent leprosy infection. The injection site is labeled and examined 3 days and 28 days later to see if there is a reaction. Mycobacterium leprae
Antigen injection
illustration
Review Date: 9/10/2015
Reviewed By: Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
